Feline Mammary Carcinomas as a Model for Human Breast Cancer: A Case-series Study
Archives of Advances in Biosciences,
Vol. 14 No. 1 (2023),
19 February 2023
,
Page 1-6
https://doi.org/10.22037/aab.v14i1.41137
Abstract
Introduction: Feline mammary carcinoma (FMC) is the third most common cancer in cats. Diagnosis of mammary gland tumors (MGTs) increases every year; this might be due to the rise in occurrence or improvements in methods of detecting MGTs. Determinants associated withtheir occurrence are studied in the present paper.
Materials and Methods: In this case-series study, 40 queens with FMC were referred to the determined major veterinary hospitals of Tehran for treatment between 2020 and 2022; their mammary carcinoma had been confirmed by the attended pathologist. Different parameters including age of cancer diagnosis, breed, reproductive status, BCS, diet type, parity, tumor size, multiple tumors, ER and PR status, location and type of treatment were recorded on the day of presentation using a checklist.
Results: Domestic short hairs were overrepresented. Also, queens with old age (more than 9 years old), homemade diet, sexually intact status, no parity, obesity, ER and PR positivity had higher frequency towards developing FMC. Imbalanced homemade diet energy is a speculated cause.
Conclusion: Humans and their companion animals share the same environment, thus being exposed to the same environmental risks. Although canine mammary tumors have been the focus of human breast cancer (HBC) modeling, this study also aimed to compare current feline mammary carcinoma determinants with previously defined human breast cancer determinants to produce a model. Based on the results of this study, we concluded that FMCs are a proper model to study HBC.
- Determinants
- Human mode
- Tehran
How to Cite
References
Varma CG, Teja A, Lavanya K. Assessment of risk factors for incidence of canine mammary tumors.
J Pharm Innov. 2021; 10(5):554-6. https://www.researchgate.net/profile/Allu-Teja-2/publication/351955622_
Serpell JA. Domestication and history of the cat. The domestic cat: The biology of its behaviour.
Cambridge: Cambridge University Press; 2000. https://www.scirp.org/(S(351jmbntvnsjt1aadkposzje))/reference/referencespapers.aspx?referenceid=1947397
Murray JK, Gruffydd‐Jones TJ, Roberts MA, Browne WJ. Assessing changes in the UK pet cat and dog populations: numbers and household ownership. Vet Rec. 2015; 177(10):259. [DOI:10.1136/vr.103223] [PMID]
Zappulli V, De Zan G, Cardazzo B, Bargelloni L, Castagnaro M. Feline mammary tumours in comparative oncology. J Dairy Res. 2005; 72(S1):98-106. [DOI:10.1017/s0022029905001263] [PMID]
Cannon CM. Cats, cancer and comparative
oncology. Veterinary sciences. 201; 2(3):111-26. [DOI: 10.3390/vetsci2030111] [PMID]
Novosad CA. Principles of treatment for mammary gland tumors. Clin Tech Small Anim Pract. 2003; 18(2):107-9. [DOI:10.1053/svms.2003.36625] [PMID]
Zappulli V, Rasotto R, Caliari D, Mainenti M, Peña L, Goldschmidt MH, et al. Prognostic evaluation of feline mammary carcinomas: a review of the literature. Vet Pathol. 2015; 52(1):46-60. [DOI:10.1177/0300985814528221] [PMID]
Lindblad-Toh K, Wade CM, Mikkelsen TS, Karlsson EK, Jaffe DB, Kamal M, et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature. 2005; 438(7069):803-19. [DOI:10.1038/nature04338] [PMID]
Tamazian G, Simonov S, Dobrynin P, Makunin A, Logachev A, Komissarov A, et al. Annotated features of domestic cat–Felis catus genome. Gigascience. 2014; 3:1-3. [DOI:10.1186/2047-217X-3-13] [PMID]
Vail DM, Thamm DH, Liptak J. Withrow and MacEwen's Small animal clinical oncology-
E-Book. Elsevier Health Sciences; 2019. https://www.elsevier.com/books/withrow-and-macewens-small-animal-clinical-oncology/9781437723625
Giménez F, Hecht S, Craig LE, Legendre AM. Early detection, aggressive therapy: optimizing the management of feline mammary masses. J Feline Med Surg. 2010; 12(3):214-24. [DOI:10.1016/j.jfms.2010.01.004]
Soares M, Correia J, Peleteiro MC, Ferreira F. St Gallen molecular subtypes in feline mammary carcinoma and paired metastases—disease progression and clinical implications from a 3-year follow-up study. Tumour Biol. 2016; 37:4053-64. [DOI:10.1007/s13277-015-4251-z] [PMID]
OCU. Feline mammary tumors. 2023. Available from: https://vet.osu.edu/vmc/companion/our-services/oncology-and-hematology/common-tumor-types/feline-mammary-tumors
Overley B, Shofer FS, Goldschmidt MH, Sherer D, Sorenmo KU. Association between ovarihysterectomy and feline mammary carcinoma. J Vet Intern Med. 2005; 19(4):560-3. [DOI:10.1892/0891-6640(2005)19[560:aboafm]2.0.co;2] [PMID]
Hayes Jr HM, Milne KL, Mandell CP. Epidemiological features of feline mammary carcinoma. Vet Rec. 1981; 108(22):476-9. [DOI:10.1136/vr.108.22.476] [PMID]
Withrow SJ, MacEwen EG. Tumours of the mammary gland: small animal clinical oncology. 3rd ed. Philadelphia; 2001.
Misdorp W, Romijn A, Hart AA. Feline mammary tumors: a case-control study of hormonal factors. Anticancer Res. 1991; 11(5):1793-7. [PMID]
Hayden DW, Nielsen SW. Feline mammary turnours. J Small Anim Pract. 1971; 12(12):687-98. [DOI:10.1111/j.1748-5827.1971.tb06197.x] [PMID]
Hayes AA, Mooney S. Feline mammary tumors. Vet Clin North Am Small Anim Pract. 1985; 15(3):513-20. [DOI:10.1016/s0195-5616(85)50054-6] [PMID]
Weijer K, Head KW, Misdorp W, Hampe JF. Feline malignant mammary tumors. I. Morphology and biology: some comparisons with human and canine mammary carcinomas. J Natl Cancer Inst. 1972; 49(6):1697-704. [DOI:10.1093/jnci/49.6.1697] [PMID]
McGuire A, Brown JA, Malone C, McLaughlin R,
Kerin MJ. Effects of age on the detection and management of breast cancer. Cancers. 2015; 7(2):908-29. [DOI:10.3390/cancers7020815] [PMID] [PMCID]
Dorn CR, Taylor DO, Schneider R, Hibbard HH, Klauber MR. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. J Natl Cancer Inst. 1968; 40(2):307-18. [PMID]
Misdorp W, Romijn A, Hart AA. The significance of ovariectomy and progestagens in the development of mammary carcinoma in cats. Tijdschr Diergeneeskd. 1992; 117(1):2-4.
Skorupski KA, Overley B, Shofer FS, Goldschmidt MH, Miller CA, Sørenmo KU. Clinical characteristics of mammary carcinoma in male cats. Journal of Veterinary Internal Medicine. 2005 Jan;19(1):52-5. [PMID]
Mogren I, Stenlund H, Ulf Högberg U. Long-term impact of reproductive factors on the risk of cervical, endometrial, ovarian and breast cancer. Acta Oncol. 2001; 40(7):849-54. [DOI:10.1080/02841860152703481] [PMID]
Katuwal S, Tapanainen J, Pukkala E. Multivariate analysis of independent roles of socioeconomic status, occupational physical activity, reproductive factors, and postmenopausal hormonal therapy in risk of breast cancer. Breast Cancer Res Treat. 2022; 193(2):495-505. [DOI:10.1007/s10549-022-06571-x] [PMID] [PMCID]
Wood CJ, Chu ML, Selmic LE, Mayhew PD, Holt DE, Martano M, et al. Effect of perioperative desmopressin in cats with mammary carcinoma treated with bilateral mastectomy. Vet Comp Oncol. 2021; 19(4):724-34. [DOI:10.1111/vco.12636] [PMID]
McNeill CJ, Sorenmo KU, Shofer FS, Gibeon L, Durham AC, Barber LG, et al. Evaluation of adjuvant doxorubicin‐based chemotherapy for the treatment of feline mammary carcinoma. J Vet Intern Med. 2009; 23(1):123-9. [DOI:10.1111/j.1939-1676.2008.0244.x] [PMID]
Weijer K, Hart AA. Prognostic factors in feline mammary carcinoma. J Natl Cancer Inst. 1983; 70(4):709-16. [PMID]
Zatloukal J, Lorenzova J, Tichý F, Nečas A, Kecova H, Kohout P. Breed and age as risk factors for canine mammary tumours. Acta Veterinaria Brno. 2005; 74(1):103-9. [DOI:10.2754/avb200574010103]
Gameiro A. Improving feline mammary carcinoma treatment through HER2-related immunochemotherapy agents and biomarkers. Universidade de Lisboa, Faculdade de Medicina Veterinária; 2022. https://www.repository.utl.pt/handle/10400.5/24669
Burrai GP, Mohammed SI, Miller MA, Marras V, Pirino S, Addis MF, et al. Spontaneous feline mammary intraepithelial lesions as a model for human estrogen receptor-and progesterone receptor-negative breast lesions. BMC Cancer. 2010; 10(1):1-11. [DOI:10.1186/1471-2407-10-156] [PMID] [PMCID]
Niel MV, Millán Y, Ordás J, Blankenstein MA, Mil FV, Misdorp W. Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status. Res vet sci. 2002; 72(2):153-61. [DOI:10.1053/rvsc.2001.0542] [PMID]
Gameiro A, Urbano AC, Ferreira F. Emerging biomarkers and targeted therapies in feline mammary carcinoma. Vet Sci. 2021; 8(8):164. [DOI:10.3390/vetsci8080164] [PMID] [PMCID]
- Abstract Viewed: 142 times
- PDF Downloaded: 70 times